Retraction

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1172/JCI81878
Additional Notes:

Stephanie Watkins responsible; JME 06/27/2017

Citations (68)

68
Total Citations
22
Post-Retraction
(32.4%)
38
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
2 Within 30 days
8 Within 1 year
10 After 2+ years
3393 Days since retraction (latest)
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing FOXO3 A Master Switch for Regulating Tolerance and...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Immunity to Murine Prostatic Tumors: Continuous Pr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Chimeric Antigen Receptor–Modified T Cells in Chro...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Decreased Warburg Effect Induced by ATP Citrate Ly...
Unknown Authors
Unknown Journal
Published: Aug 2024
3393 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2023
3058 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Aug 2022
2668 days after retraction
Role of Forkhead box O3a transcription factor in autoimmune diseases
Shanshan Xu, Yubo Ma, Yuting Chen et al. (4 authors)
International Immunopharmacology
Published: Jan 2021
27 citations
2081 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2020
1950 days after retraction
Paper citing Inactivation of PI(3)K p110delta breaks regulatory...
Unknown Authors
Unknown Journal
Published: Nov 2019
1672 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2019
1584 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2019
1584 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Jan 2019
1341 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Oct 2017
910 days after retraction
Paper citing FOXO3 A Master Switch for Regulating Tolerance and...
Unknown Authors
Unknown Journal
Published: Feb 2017
661 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Jul 2016
441 days after retraction
Aspects immunologiques du cancer de l’ovaire : perspectives thérapeutiques
M. Nayama, P. Collinet, Michel Salzet et al. (4 authors)
Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
Published: Jun 2016
2 citations
417 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: May 2016
366 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Feb 2016
283 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Dec 2015
222 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Dec 2015
214 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2015
123 days after retraction
Paper citing Chimeric Antigen Receptor–Modified T Cells in Chro...
Unknown Authors
Unknown Journal
Published: Aug 2015
92 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Jul 2015
74 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: May 2015
19 days after retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: May 2015
12 days after retraction
Paper citing Macrophage Colony-Stimulating Factor Augments Tie2...
Unknown Authors
Unknown Journal
Published: Apr 2015
30 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Mar 2015
42 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Feb 2015
81 days before retraction
Food Intolerance: Associations with the rs12212067 Polymorphism of FOXO3 in Crohn's Disease Patients in New Zealand
Gareth Marlow, Dug Yeo Han, Christopher M. Triggs et al. (4 authors)
Lifestyle Genomics Open Access
Published: Jan 2015
14 citations
120 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Dec 2014
134 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Nov 2014
156 days before retraction
Stromal-dependent tumor promotion by MIF family members
Robert A. Mitchell, Kavitha Yaddanapudi
Cellular Signalling Open Access
Published: Sep 2014
19 citations
213 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2014
217 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2014
220 days before retraction
Paper citing FOXO3 A Master Switch for Regulating Tolerance and...
Unknown Authors
Unknown Journal
Published: Aug 2014
263 days before retraction
Paper citing FOXO3 A Master Switch for Regulating Tolerance and...
Unknown Authors
Unknown Journal
Published: Aug 2014
271 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: May 2014
347 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: May 2014
350 days before retraction
Paper citing FOXO3 A Master Switch for Regulating Tolerance and...
Unknown Authors
Unknown Journal
Published: Apr 2014
386 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Feb 2014
452 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Dec 2013
492 days before retraction
Paper citing Update on the Application of Interleukin-2 in the ...
Unknown Authors
Unknown Journal
Published: Nov 2013
519 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2013
590 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Sep 2013
598 days before retraction
Paper citing FOXO3 programs tumor-associated DCs to become tole...
Unknown Authors
Unknown Journal
Published: Aug 2013
611 days before retraction
Quick Stats
Total Citations: 68
Years Since Retraction: 10.6 years
Open Access: Yes
Last Checked: Never
Related Papers
Sorting protein VPS33B regulates exosomal autocrine signali…
The Journal of Clinical Investigation (JCI) • 74 citations
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulate…
The Journal of Clinical Investigation (JCI) • 82 citations
NK cell heparanase controls tumor invasion and immune surve…
The Journal of Clinical Investigation (JCI) • 94 citations
TIGIT predominantly regulates the immune response via regul…
The Journal of Clinical Investigation (JCI) • 521 citations
Host immunity contributes to the anti-melanoma activity of …
The Journal of Clinical Investigation (JCI) • 268 citations